Cargando…
419. Viral SARS-CoV-2 rebound rates in linked commercial pharmacy-based SARS-CoV-2 RT-qPCR testing and healthcare claims
BACKGROUND: Viral SARS-CoV-2 RNA rebound has been described as a positive viral antigen or PCR test that follows a negative test. Although early descriptions of this phenomenon were linked to nirmatrelvir/ritonavir (NMV-r) treatment, subsequent studies have shown that viral rebound occurs both in un...
Autores principales: | Luo, Shishi, McEwen, Lisa M, Kelly, Scott P, Isaksson, Magnus, Murphy, Sarah, White, Simon, McCrone, J T, Levan, Geraint, Santhanam, Sharad, Baniecki, Mary Lynn, Bramson, Candace, Rubino, Heather, Hendrick, Victoria, Soares, Holly, Hammond, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677905/ http://dx.doi.org/10.1093/ofid/ofad500.489 |
Ejemplares similares
-
SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023) -
419. SARS-CoV-2 Environmental Surface Contamination of Healthcare Staff Common Areas
por: Zhang, Helen L, et al.
Publicado: (2021) -
An explanation for SARS-CoV-2 rebound after Paxlovid treatment
por: Perelson, Alan S., et al.
Publicado: (2023) -
SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy
por: Edelstein, Gregory E., et al.
Publicado: (2023) -
Evidence for SARS-CoV-2 Delta and Omicron co-infections and recombination
por: Bolze, Alexandre, et al.
Publicado: (2022)